Dear Shareholder,
DICE Molecules Holdings LLC has finalised an IPO and subsequent listing on the Nasdaq, it is trading under the ticker DICE.
The IPO was priced at USD $17.00 per share, subsequent trading has lifted it again to USD $37.00 per share. The market capitalisation of the entity was USD $1,269,717,604 as at close of trade Friday, 17 September 2021.
This marks it as an American Unicorn Company. Gowing Bros. Limited was a foundation investor in DICE Molecules and has held shares in the Company from 2014. DICE has a leading proprietary technology that assists in identifying and treating chronic illnesses.
The Group has no intention of selling shares at this point in time.
The Group invested USD $1,100,000 over the 2014 – 2018 period, the parcel is now worth USD $7,100,000 (AUD $9,700,000). Representing a 6.7X return on investment in USD over seven years.
The underlying increase in the value of the Group’s holding is approximately AUD $7,000,000 as at 20 September 2021, this represents a material uplift in the Group’s net assets per share.
Yours sincerely, John Gowing, Managing Director1
DYOR
i hold GOW
well they certainly needed a win like that to catch some headlines
that said their mixed investment strategy is what encouraged me to throw a few bucks at this in September 2019